Skip to main content
. 2018 Nov 13;11(11):2265. doi: 10.3390/ma11112265

Table 3.

Antibiotics tested in this study.

Antibiotic Manufacturer
Amikacin Sulfate Hospira Ltd., Maidenhead, UK
Ceftriaxone Sodium Apotex Corporation, Toronto, ON, Canada
Cefuroxime Stravencon, London, UK
Ciprofloxacin Hydrochloride Medisca Inc., Las Vegas, NV, USA
Colistamethane Sodium Sigma-Aldrich, Dorset, UK
Clindamycin (Dalacin C® Phosphate) Pfizer, Tadworth, UK
Daptomycin (Cubicin®) Novartis, Basel, Switzerland
Gentamicin Sulfate Hospira Ltd., Maidenhead, UK
Imipenem/Cilastatin (Zienam®) Merck & Co., Inc, Kenilworth, NJ, USA
Meropenem Trihydrate Fresenius Kabi Ltd., Cestrian, UK
Nafcillin Sodium Sandoz, Princeton, NJ, USA
Rifampicin Sigma-Aldrich, Dorset, UK
Teicoplanin (Targocid®) Sanofi-Aventis, Guildford, UK
Tobramycin Sulfate Hospira Ltd., Maidenhead, UK
Vancomycin Hydrochloride Hospira Ltd., Maidenhead, UK